Therapeutic delivery for patient-centric care
The future of biologic drug delivery extends beyond traditional intravenous and subcutaneous administration. As biologics continue to grow in importance, there is increasing demand for delivery methods that improve patient experience while maintaining therapeutic efficacy.
By leveraging the biologically active environment of the skin, intradermal administration may improve bioavailability, reduce administered volumes, and support more efficient use of high-value biologic medicines. This makes intradermal delivery an attractive strategy to maximize therapeutic performance while advancing patient-centric care.
Therapeutic applications for medicinal products: precise and patient-friendly
VAX-ID, our patented medical device, supports precise, reliable intradermal delivery across a broad range of therapeutic applications, from oncology and immunology to regenerative medicine, dermatology, and beyond. By enabling accurate, dose-sparing administration, VAX-ID is built to support the next generation of advanced therapies.
Easy to use
Accurate delivery
CE marked device
Why therapeutic vaccines matter?
Therapeutic vaccination has the potential to improve cancer treatment outcomes. Today, numerous preclinical and clinical trials with different types of therapeutic vaccines are ongoing.
Following the success of COVID-19 mRNA vaccines and significant investments in research and development, mRNA technology is revolutionizing the future of medicine.
A deeper dive into the backbone of the vaccine: LNPs
The success of modern therapeutic vaccines depends not only on the therapeutic molecule itself but also on delivering it effectively to the right immune cells. Advanced delivery technologies such as lipid nanoparticles (LNPs) protect fragile RNA molecules from degradation and enhance cellular uptake, while intradermal delivery targets the skin’s rich network of antigen-presenting cells to improve treatment effectiveness.
As interest in mRNA-based therapeutic vaccines for cancer continues to grow, the combination of LNPs and intradermal administration is emerging as a powerful strategy. By improving stability, bioavailability, and immune activation, these approaches may help unlock the potential of possibly more effective therapeutic vaccines.
Why advanced therapies matter?
Advanced therapy medicinal products (ATMPs)
Standard injection methods can damage sensitive biologics and cell-based therapies through shear stress and viscosity-related counterpressure. Our VAX-ID device is engineered to protect cell and compound integrity during delivery, a foundation that applies across a variety of therapeutic areas.
Targeted delivery of therapeutics
Read our white papers and application notes on intradermal injections for therapeutic use. Get to the heart of our applications and learn more about the science behind the route of administration for:
Oncology-immunology
Intraderml delivery targets the skin’s dense network of immune cells, making it a promising route for cancer vaccines and immunotherapies.
Dermatology
Intradermal delivery is a well-established approach for the targeted delivery of products for a broad range of skin conditions.
VAX-ID: One platform, multiple applications
VAX-ID is our CE-marked intradermal injection device designed to standardize intradermal delivery of medicinal products by eliminating variability in injection depth and angle.
Used across oncology, autoimmune diseases, dermatology, and other therapeutic areas, VAX-ID consistently targets the immune cell-rich dermis with high precision. By reducing operator-dependent variability, the device helps support cell viability, dose accuracy, safety, and reproducible clinical outcomes with every injection.
Safe
User-friendly
Low in pain
Interested in improving drug delivery for your therapy?
Wondering what Idevax can do for your project? Talk to our team about your specific delivery needs.
Discover our solutions for preventive applications and diagnostic applications as well.
"*" indicates required fields